Expression of maspin and angiogenin in nasopharyngeal carcinoma: Novel preliminary clinico-pathological evidence

Acta Oto-Laryngologica

Volumn 130, Issue 8, 2010, Pages 952-958

  Marioni, Gino ^a   Koussis, Haralabos ^b   Scola, Annamaria ^c   Maruzzo, Marco ^b   Giacomelli, Luciano ^a   Karahontziti, Paraskevi ^d   De Filippis, Cosimo ^a   Staffieri, Alberto ^a   Blandamura, Stella ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^c Azienda ULSS ^*  (Greece)

^d IASO   (Greece)

Author keywords

Angiogenesis; Chemo radiotherapy; Prognosis

Indexed keywords

ANGIOGENIN; CARBOPLATIN; CISPLATIN; EPIRUBICIN; ETOPOSIDE; KI 67 ANTIGEN; MASPIN; PANCREATIC RIBONUCLEASE; SERINE PROTEINASE INHIBITOR; SERPIN-B5;

ADULT; ARTICLE; CANCER SURVIVAL; CARCINOMA CELL; CAUCASIAN; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CYTOPLASM; DISEASE FREE SURVIVAL; FEMALE; HUMAN; MALE; METASTASIS; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TUMOR VASCULARIZATION; CARCINOMA; METABOLISM; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; TREATMENT OUTCOME;

ADULT; CARCINOMA; FEMALE; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; PROGNOSIS; RIBONUCLEASE, PANCREATIC; SERPINS; TREATMENT OUTCOME;

EID: 77954651983     PISSN: 00016489     EISSN: 16512553     Source Type: Journal    
DOI: 10.3109/00016480903518034     Document Type: Article

References (20)

1. Chong VFH, Ong CK. Nasopharyngeal carcinoma. Eur J Radiol 2008;66:437-447
2. Chou J, Lin YC, Kim J, You L, Xu Z, He B, et al. Nasopharyngeal carcinoma. Review of the molecular mechanisms of tumorigenesis. Head Neck 2008;30:946-963
3. Dales JP, Garcia S, Carpentier S, Andrac L, Ramuz O, Lavaut MN, et al. Prediction of metastasis risk (11 year follow-up) using VEGF-R1, VEGF-R2, Tie-2/Tek and CD105 expression in breast cancer (n=905). Br J Cancer 2004;90:1216-1221
4. Marioni G, Staffieri C, Staffieri A, De Filippis C, Blandamura S. MASPIN tumour-suppressing activity in head and neck squamous cell carcinoma: emerging evidence and therapeutic perspectives. Acta Otolaryngol 2009;129: 476-480
5. Khalkhali-Ellis Z.Maspin: the new frontier. Clin Cancer Res 2006;12:7279-7283
6. Bailey CM, Khalkhali-Ellis Z, Seftor EA, Hendrix MJ. Biological functions of maspin. J Cell Physiol 2006;209:617-624
7. Dickson KA, Kang DK, Kwon YS, Kim JC, Leland PA, Kim BM, et al. Ribonuclease inhibitor regulates neovascularization by human angiogenin. Biochemistry 2009;48:3804-3806
8. Tello-Montoliu A, Patel JV, Lip GYH. Angiogenin: a review of the pathophysiology and potential clinical applications. J Thromb Haemost 2006;4:1864-1876
9. Sharma S, Sharma MC, Sarkar C. Morphology of angiogenesis in human cancer: a conceptual overview, histoprognostic perspective and significance of neoangiogenesis. Histopathology 2005;46:481-489
10. Roychowdhury DF, Tseng A Jr, Fu KK, Weinburg V, Weidner N. New prognostic factors in nasopharyngeal carcinoma. Tumor angiogenesis and C-erbB2 expression. Cancer 1996;77:1419-26.
11. Rubio L, Burgos JS, Lopez-Guerrero JA, Morera C, Vera-Sempere FJ. Expression of p53 protein and tumor angiogenesis as prognostic factors in nasopharyngeal carcinoma patients. Pathol Res Pract 2002;198:97-102.
12. Ma BB, Poon TC, To KF, Zee B, Mo FK, Chan CM, et al. Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma - a prospective study. Head Neck 2003; 25:864-872
13. Foote RL, Weider N, Harris J, Hammond E, Lewis JE, Vuong T, et al. Evaluation of tumor angiogenesis measured with microvessel density (MVD) as a prognostic indicator in nasopharyngeal carcinoma: results of RTOG 9505. Int J Radiat Oncol Biol Phys 2005;61:745-753
14. Guang-Wu H, Sunagawa M, Jie-En L, Shimada S, Gang Z, Tokeshi Y, et al. The relationship between microvessel density, the expression of vascular endothelial growth factor (VEGF), and the extension of nasopharyngeal carcinoma. Laryngoscope 2000;110:2066-2069
15. Nasr HB, Chahed K, Bouaouina N, Chouchane L. Functional vascular endothelial growth factor -2578 C/A polymorphism in relation to nasopharyngeal carcinoma risk and tumor progression. Clin Chim Acta 2008;395: 124-129
16. Pan J, Kong L, Lin S, Chen G, Chen Q, Lu JJ. The clinical significance of coexpression of cyclooxygenases-2, vascular endothelial growth factors, and epidermal growth factor receptor in nasopharyngeal carcinoma. Laryngoscope 2008; 118:1970-1975
17. Marioni G, D'Alessandro E, Giacomelli L, De Filippis C, Calgaro N, Sari M, et al. Maspin nuclear localization is related to reduced density of tumour-associated micro-vessels in laryngeal carcinoma. Anticancer Res 2006;26:4927-4932
18. Homer JJ, Greenman J, Stafford ND. Circulating angiogenic cytokines as tumour markers and prognostic factors in head and neck squamous cell carcinoma. Clin Otolaryngol Allied Sci 2002;27:32-37
19. Xia B, Yang T, Xian J, Wang J. Serum angiogenin concentration in nasopharyngeal carcinoma patients and its clinical significance. Lin Chuang Er Bi Yan Hou Ke Za Zhi 2006; 20:647-648
20. Gao X, Xu Z. Mechanisms of action of angiogenin. Acta Biochim Biophys Sin 2008;40:619-624